Deep, qualified upcoming-technology sequencing has unveiled that subclonal mutations (i.e., those existing in just a fraction of tumor cells) is usually detected for all driver genes and so are associated with swift disease development and poor outcome.11–13 This is particularly applicable for TP53 mutations offered The reality that, as defined https://georges222lpu0.activoblog.com/profile